Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (25878)	9/29/1998 9:58:00 PM
From: bob zagorin	Read Replies (2) \| Respond to of 32384

thanks for posting David Molowa's analysis. It confirms my first reaction to the deal, that it is quite significant and provides LGND the cash to make the transition from research company with no earnings to full-fledged pharm. don't know why but i seem to have more confidence in Bear Stearns than some of the knee jerk negatives posted by mudcat etc. another stock i own, PSIX, got a $500m cash infusion on a 10% note and has been using it to consolidate a lot of small ISPs as it builds its network. i'm really curious as to any guestimates as to where LGND might go in a similar vein. what type of technology might they find complimentary and who might have. Is Ribozyme a legitmate candidate? to my amateur mind, the technologies seem complimentary.